Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
14.07
+0.62 (4.61%)
Aug 14, 2025, 11:43 AM - Market open

Syndax Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
108.64154.08295.3974.36221.97115.24
Upgrade
Short-Term Investments
360.07428.83282.19410.04224.87182.51
Upgrade
Cash & Short-Term Investments
468.71582.91577.58484.4446.83297.75
Upgrade
Cash Growth
8.43%0.92%19.24%8.41%50.07%387.54%
Upgrade
Accounts Receivable
19.457.6----
Upgrade
Other Receivables
17.976.271.234.060.430.2
Upgrade
Receivables
37.4213.871.234.060.430.2
Upgrade
Inventory
17.70.37---0.06
Upgrade
Prepaid Expenses
6.385.321.220.870.43
Upgrade
Restricted Cash
----0.120.12
Upgrade
Other Current Assets
1.470.610.060.120.150.32
Upgrade
Total Current Assets
531.68603.06580.88489.79448.4298.86
Upgrade
Property, Plant & Equipment
1.632.021.51.061.260.48
Upgrade
Long-Term Investments
62.63119.5229.835.47--
Upgrade
Other Long-Term Assets
0.220.220.680.92-1.27
Upgrade
Total Assets
596.15724.82612.88497.24449.66300.61
Upgrade
Accounts Payable
17.3511.639.964.355.673.51
Upgrade
Accrued Expenses
75.2359.6838.9723.6712.7611.25
Upgrade
Current Portion of Long-Term Debt
19.4412.12---2.29
Upgrade
Current Portion of Leases
0.350.481.050.440.360.32
Upgrade
Current Unearned Revenue
-----1.52
Upgrade
Other Current Liabilities
0.6219.658.120.61.89-
Upgrade
Total Current Liabilities
112.99103.5558.129.0720.6818.87
Upgrade
Long-Term Debt
324.41331.57--19.917.83
Upgrade
Long-Term Leases
1.331.580.590.720.710.1
Upgrade
Long-Term Unearned Revenue
-----11.62
Upgrade
Other Long-Term Liabilities
-----0
Upgrade
Total Liabilities
438.73436.6958.6829.7941.2948.43
Upgrade
Common Stock
0.010.010.010.010.010.01
Upgrade
Additional Paid-In Capital
1,5351,5091,4561,161952.02820.82
Upgrade
Retained Earnings
-1,378-1,221-902.4-693.04-543.7-568.63
Upgrade
Comprehensive Income & Other
0.290.160.22-0.810.05-0
Upgrade
Total Common Equity
157.42288.12554.2467.45408.37252.19
Upgrade
Shareholders' Equity
157.42288.12554.2467.45408.37252.19
Upgrade
Total Liabilities & Equity
596.15724.82612.88497.24449.66300.61
Upgrade
Total Debt
345.52345.741.641.1620.9720.54
Upgrade
Net Cash (Debt)
123.18237.17575.95483.24425.86277.21
Upgrade
Net Cash Growth
-71.43%-58.82%19.19%13.47%53.62%360.68%
Upgrade
Net Cash Per Share
1.432.778.187.957.946.71
Upgrade
Filing Date Shares Outstanding
86.1486.0284.9768.4455.0148.24
Upgrade
Total Common Shares Outstanding
86.0685.6984.8368.1154.9847.88
Upgrade
Working Capital
418.69499.51522.78460.72427.71279.99
Upgrade
Book Value Per Share
1.833.366.536.867.435.27
Upgrade
Tangible Book Value
157.42288.12554.2467.45408.37252.19
Upgrade
Tangible Book Value Per Share
1.833.366.536.867.435.27
Upgrade
Machinery
-0.250.250.250.540.41
Upgrade
Leasehold Improvements
-0.170.170.170.170.17
Upgrade
Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q